Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if giving Omegaven (an intravenous fat emulsion
containing fish oil) instead of the current lipid emulsion, which contains fat derived from
soybeans, as part of your child's intravenous (IV) nutrition therapy may be tolerated better.
It may reduce the harmful effects to the liver, may stop any further liver damage and may
reverse damage already done to the liver because of the prolonged use of nutrition through
your child's IV.